LATEST PSYCHEDELICS STOCKS NEWS

Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial

TORONTO, April 23, 2020 -- Revive Therapeutics Ltd. (β€œRevive” or the β€œCompany”) (CSE:RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has received positive feedback from the U.S. Food and Drug Administration (β€œFDA”) in response to ... Read More...

Champignon Commences U.S. Trading on the OTCQB Venture Market Under Ticker Symbol β€œSHRMF”

VANCOUVER, British Columbia, April 23, 2020 -- Champignon Brands Inc. (β€œChampignon” or the β€œCompany”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to anno... Read More...

Hollister Biosciences Enters Into Definitive Agreement to Acquire AlphaMind Brands Inc.

VANCOUVER , April 23, 2020 - Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT : HOB, OTC: HSTRF) (the "Company" or " Hollister ") – a diversified cannabis branding company with products in over 220 dispensaries throughout California , is pleased to announce that it has entered into a share exchange agreement dated April 22 nd, 2020 among ... Read More...

NewLeaf Brands Signs Acquires 50% of Dallas, Texas Based Distribution Company Levee Street Holdings, LLC

VANCOUVER , British Columbia , April 23, 2020 --Β NewLeaf Brands Inc. (NLB.CN) (NLBIF) (0NF.F) ("NewLeaf Brands") is pleased to announce that it has signed a share swap agreement with Levee Street Holdings, LLC ("Levee Street") to purchase 50% of Levee Street for $450,000 CAD in common shares. Greg Kassanoff founded Levee Street to infiltr... Read More...

Empower Clinics Continues to Advance Development of Psilocybin and Psychedelics Division to Address Significant Mental Health Issues

Empower is utilizing clinics, physicians, technology and direct access to 165,000 patients to launch dedicated division and resources for psilocybin research.VANCOUVER, BC / ACCESSWIRE / April 22, 2020 / EMPOWER CLINICS INC. (CBDT.CN)(EPWCF)(Frankfurt 8EC) ("Empower"), a vertically integrated and growth-oriented life sciences company is p... Read More...

Champignon Secures Stable Psilocybin Supply Under DEA Schedule I License for TBI/PTSD Studies at the University of Miami

VANCOUVER, British Columbia, April 22, 2020 -- Champignon Brands Inc. (β€œChampignon” or the β€œCompany”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, continues to advan... Read More...

Osoyoos Enters into Equipment Lease and Joint-Venture Agreement; Provides Corporate Update

Toronto, Ontario--(Newsfile Corp. - April 21, 2020) - Osoyoos Cannabis Inc. (CSE: OSO) ("Osoyoos" or the "Company") announced today that the Company has entered into an equipment lease (the "Equipment Lease") and a joint-venture agreement (the "JV Agreement") with 2623942 Ontario Limited (the "Licensed Producer"). Furthermore, the Company... Read More...

Psychedelic Pharmaceutical Company MindMed Develops LSD Neutralizer Technology To Shorten and Stop LSD Trips

Advances Discovered in Collaboration with University Hospital Basel's Liechti Laboratory and Aims To Enhance Therapeutic Potential of PsychedelicsNEW YORK, April 21, 2020 --Β Mind Medicine (MindMed) Inc. (NEO: MMED OTCQB: MMEDF), in collaboration with University Hospital Basel's Liechti Laboratory, has discovered and filed a patent applica... Read More...

Revive Therapeutics Announces Research Partnership Agreement with the University of Wisconsin-Madison to Evaluate Novel Formulations and Drug Delivery Technology Focused on Psilocybin-Based Pharmaceuticals

TORONTO, April 21, 2020 -- Revive Therapeutics Ltd. (β€œRevive” or the β€œCompany”) (CSE:RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has entered into a sponsored research partnership agreement (β€œSRPA”) with the University of Wisco... Read More...

PSYC Primed for Launch During Covid-19

Las Vegas, NV, April 21, 2020 -- Global Trac Solutions, Inc. (PSYC) (β€œGlobal” β€œPSYC” or the β€œCompany”) is pleased to announce they have engaged with a variety of key industry experts in an effort to plan and prepare for the Company’s intended initial launch set for May 2020. Such efforts have included identifying and establishing strategi... Read More...

Hydroxychloroquine Treatment for COVID-19 Benefits Sought in Global Research Effort to Establish Efficacy

Codebase investee has secured rights to Transdermal Hydroxychloroquine Drug Delivery SystemVANCOUVER, BC / ACCESSWIRE / April 20, 2020 / Codebase Ventures Inc. ("Codebase") (CODE.CN)(C5B.F)(BKLLF), an investment company, is pleased to build upon its announcement of April 16th regarding its binding letter of intent to invest in an arms-len... Read More...

Hollister Biosciences Inc. Division Hollister Cannabis Co Becomes Official Brand Partner for Chronic Relief 4/20 Fundraiser in Support of Feeding America

Hollister Biosciences Inc., the creator of California's #1 hash-infused pre-roll HashBone, joins a global group of cannabis' biggest stars for an unprecedented live web broadcast on one of the world's "highest" holidays to feed hungry families during the global coronavirus pandemic. Β VANCOUVER , April 20, 2020 - Hollister Biosciences Inc.... Read More...

MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations

Company is actively developing and scaling manufacturing processes for 18-MC and LSD APIs to be used in the company's future drug trialsNEW YORK, April 20, 2020 --Β Mind Medicine (MindMed), Inc. (NEO: MMED; OTCQB: MMEDF), the leading psychedelic pharmaceutical company, today announced the promotion of pharmaceutical industry veteran Jeanne... Read More...

Champignon Receives DTC Eligibility

VANCOUVER, British Columbia, April 17, 2020 -- Champignon Brands Inc. (β€œChampignon” or the β€œCompany”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to anno... Read More...

Graph Blockchain Applauds Shareholder Datametrex AI Limited for Their Response to the Covid-19 Pandemic

Toronto, Ontario--(Newsfile Corp. - April 17, 2020) - Graph Blockchain Inc. (CSE: GBLC) ("Graph" or "Company") applauds Datametrex Limited (TSXV: DM) (FSE: D4G) (minority interest shareholder of 26% of the Company) for securing the rights to import COVID-19 detection kit into Canada and other countries around the globe. See Press Release ... Read More...

Revive Therapeutics Partners with Complete Phytochemical Solutions to Advance Research Initiatives for Psilocybin-Based Pharmaceutical Products

TORONTO, April 17, 2020 -- Revive Therapeutics Ltd. (β€œRevive” or the β€œCompany”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced today that it has engaged Complete Phytochemical Solutions, LLC., an internationally-recognized company specia... Read More...

Empower Clinics Announces Closing of Private Placement the Launch of Immune System Tele-Medicine Services and Patient Visits Up 480%

Empower Clinics closes private placement of $653,000.00 to support the Company growth plan and goes live with physician based immune boosting tele-medicine consultations with online professional supplement dispensingVANCOUVER, BC / ACCESSWIRE / April 17, 2020 / EMPOWER CLINICS INC. (CBDT.CN)(8EC.F)(EPWCF) ("Empower"), a vertically integra... Read More...

MindMed Announces U.S. Trading on the OTCQB Venture Market Under Symbol MMEDF

NEW YORK, April 17, 2020 --Β Mind Medicine (MindMed) Inc. (NEO: MMED; OTCQB: MMEDF) (the "Company" or "MindMed"),Β the leading psychedelic pharmaceutical company, is pleased to announce that the Company has graduated from the OTC Pink Open Market to the OTCQB Venture Market ("OTCQB"). MindMed's subordinate voting shares will commence tradin... Read More...

MindMed Initiates Dosing in Human Safety Study of Novel Treatment for Opioid Addiction, 18-MC

NEW YORK, April 16, 2020 -- Mind Medicine (MindMed) Inc. (NEO: MMED)(OTC: MMEDF),Β the leading psychedelic pharmaceutical company, has begun dosing the first subject in an additional Phase 1 human safety trial of 18-MC. The safety trial has commenced on time and as scheduled, even during the COVID-19 pandemic. 18-MC is a proprietary, orall... Read More...

Cyntar Ventures Inc. Announces Changes in Directors and Officers, and Update on Private Placement

Toronto, Ontario--(Newsfile Corp. - April 16, 2020) - CYNTAR VENTURES INC.Β (CSE: CYN) (the "Company") wishes to announce the appointment of Mr. Yehonatan Shachar and Mr. Alan Rootenberg, the Company's CFO, to the board of directors of the Company (the "Board") effective April 15, 2020. Mr. Harry Chew and Mr. Sonny Chew have resigned as di... Read More...

Champignon Appoints Former President of Red Bull Canada to Special Advisory Committee

VANCOUVER, British Columbia, April 16, 2020 -- Champignon Brands Inc. (β€œChampignon” or the β€œCompany”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, has further bolste... Read More...

Revive Therapeutics Announces Closing of Second TrancheΒ of Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREINTORONTO, April 15, 2020 -- Revive Therapeutics Ltd. (β€œRevive” or the β€œCompany”) (CSE:RVV), a life sciences company, is pleased to announce that further to its press releases of Februar... Read More...

Vert Provides Update

Vancouver, British Columbia--(Newsfile Corp. - April 14, 2020) - VERT Infrastructure Corp. (CSE: VVV) ("VERT" or the "Company") announces it has cancelled its previously announced $0.10 unit private placement.The company continues to look for sales opportunities of its real estate assets to reduce its debt obligations. The company's main ... Read More...

Primo Nutraceuticals Inc. Announces New Product Website Launch to Support Brand Awareness Initiative into the Natural Health & Wellness Market

VANCOUVER, British Columbia, April 14, 2020 -- PRIMO NUTRACEUTICALS INC. (CSE:PRMO) (BUGVF) (8BV.F) (8BV.F) (8BV.MU) (8BV.SG) ("Primo") is pleased to announce the launch of their new e-commerce site that promotes brand awareness and market expansion into the natural health, wellness and hemp nutraceutical market. The newly designed websit... Read More...

Mota Ventures Announces Record Number of Subscriptions Year-To-Date in March and Over 6,000 New Customers in April

VANCOUVER, BC / ACCESSWIRE / April 14, 2020 / Mota Ventures Corp. (CSE:MOTA FSE:1WZ:GR OTC PINK:PEMTF) (the "Company") is excited to announce its First Class CBD and Nature's Exclusive brands acquired over 6,000 new customers from April 1st through April 11th. Additionally, during this time period over 1,700 of the new customers purchased... Read More...

EGF Theramed Health Corp. Announces $1.7m Non-brokered Private Placement and Early Stage Due Diligence on Psilocybin Assets

Vancouver, British Columbia--(Newsfile Corp. - April 13, 2020) - Β EGF Theramed Health Corp. (CSE: TMED) (OTCQB: EVAHF) (the "Company") is pleased to announce a non-brokered private placement (the "Offering") financing of up to 3,400,000 million units (the "Units") of the Company at a price of $0.50 per Unit for gross proceeds of $1,700,00... Read More...

Global Changes Ticker Symbol to PSYC and Enters the Emerging Psychedelic Market Amidst the Covid-19 Pandemic

LAS VEGAS, April 13, 2020 -- Global Trac Solutions, Inc. (PSYC) (β€œGlobal” β€œPSYC” or the β€œCompany”) is pleased to announce they have successfully changed their name and corresponding ticker symbol to PSYC in order to align it with their newest business venture objectives.β€œPSYC has always been at the forefront of innovative technologies, ne... Read More...